1-5 of 5
Aaron Sheppard
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Analysis of hematologic improvement (HI) by time to response in Relapsed/Refractory Acute Myeloid Leukemia (AML) patients treated with olutasidenib

Free
Shira Dinner, Brian Jonas, Antonio Curti, Stephane De Botton, Pau Montesinos, Karen W.L. Yee, Gail Roboz, William Blum, Gary Schiller, Jorge Cortes, Justin Watts, Andrew Wei, Aaron Sheppard, Hua Tian, Eunice Wang
Journal: Blood
Blood (2025) 146 (Supplement 1): 3439.
https://doi.org/10.1182/blood-2025-3439
Published: 2025
Journal Articles

Assessment of real-world treatment patterns and outcomes of olutasidenib in patients with mutated isocitrate dehydrogenase 1 Acute Myeloid Leukemia previously treated with venetoclax using electronic health record data

Free
Catherine Lai, Pinkal Desai, Yasmin Abaza, Jorge Cortes, Thomas Leahy, Timothy Werwath, Amber Thomassen, Aaron Sheppard
Journal: Blood
Blood (2025) 146 (Supplement 1): 4616.
https://doi.org/10.1182/blood-2025-4616
Published: 2025
Journal Articles

Olutasidenib monotherapy in patients with mIDH1 Acute Myeloid Leukemia who received prior intensive chemotherapy

Free
Jay Yang, Joseph Jurcic, Christian Recher, Pierre Fenaux, Andrew Wei, Antonio Curti, Justin Watts, Eunice Wang, Brian Jonas, Jorge Cortes, Aaron Sheppard, Sophia Wang, Stephane De Botton
Journal: Blood
Blood (2025) 146 (Supplement 1): 5213.
https://doi.org/10.1182/blood-2025-5213
Published: 2025
Journal Articles

Treatment Patterns and Outcomes of Olutasidenib in Patients with Relapsed/Refractory (R/R) Mutated IDH1 Acute Myeloid Leukemia (AML) in the Real World

Free
Aaron Sheppard, Lixia Wang, Ravi Potluri, Eros Papademetriou
Journal: Blood
Blood (2024) 144 (Supplement 1): 7908.
https://doi.org/10.1182/blood-2024-205675
Published: 2024
Journal Articles

Effectiveness of Olutasidenib Versus Ivosidenib in Patients with Mutated Isocitrate Dehydrogenase 1 Acute Myeloid Leukemia Who Are Relapsed or Refractory to Venetoclax: The 2102-HEM-101 Trial Versus a US Electronic Health Record-Based External Control Arm

Free
Catherine E. Lai, Thomas P. Leahy, Alex Turner, Amber Thomassen, Lixia Wang, Aaron Sheppard, Jorge E. Cortes
Journal: Blood
Blood (2024) 144 (Supplement 1): 1525.
https://doi.org/10.1182/blood-2024-205601
Published: 2024